Immunome, Inc.'s revenue has grown 26% a year over three years. Revenue growth, 3-year annual rate: +26% (Biotechnology median +21%). Years of annual history on file: 7, FY2019 to FY2025, as filed.

IMNMImmunome, Inc.

Healthcare

$18.00+9.1% 1Y

$18.00

$15.2452 weeks$29.84

Is it growing?

Mixed

Revenue roughly flat (+5% year on year). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data

Revenue trend+5% in a yearSEC EDGAR · Jun 30, 2026

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.